生命科学资讯

3 new venture funds collect nearly $1B for biotech in US, EU

Chutes & Ladders—Former Roche oncology head turns to Tubulis

Baby KJ scientist launches personalized CRISPR therapy startup

Quanterix nabs Illumina’s CCO as new leader, but Leerink warns of ‘significant lift’ needed for turnaround

Madrigal pays $50M for Pfizer MASH drug with eye on Rezdiffra combo potential

Former Roche oncology head turns to Tubulis—Chutes & Ladders - fiercebiotech.com

Illumina hires former NHGRI Director Eric Green as new chief medical officer

1st biotech IPO of 2026 sees Aktis bring in $318M via upsized offering

Roche returns to MediLink with promise of $570M near-term payments for another ADC

Ollin eyes phase 3 after bispecific tops Vabysmo in early-stage trial, clearing more retinal disease faster

Quest, Labcorp add fully at-home STI test to women’s health offerings

Longtime Charles River leader Jim Foster to retire, with COO set to take the helm

Lexeo Therapeutics, J&J team up to test heart pump technology for cardiac gene therapy delivery

Flagship-founded Tessera plans to lay off 90 employees in March

GSK inks a model deal in $50M bet on Noetik's cancer AI platform

Startup Spiro Medical snares $67M in series A funding for asthma treatment

Immuneering touts 64% 1-year survival, keeping wheels turning in race with Revolution

Innovation isn't enough: Biopharma needs urgent reinvention, PwC says

Diagonal moves forward with $125M series B round, plots first-in-human study this year

WEP Clinical grabs European CRO Siron Clinical, broadening global capabilities